SCHEMBL25289261

SCHEMBL25289261

NNC(=O)C(CC1CCCC1)NC(=O)OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 8/20 0.61
▸ CTSB P07858 4/20 0.61
▸ CTSS P25774 3/20 0.61
▸ CTSL P07711 3/20 0.61
▸ CASP1 P29466 1/20 0.52
▸ TACR1 P25103 2/20 0.49
▸ KDM1A O60341 3/20 0.48
▸ MAOA P21397 2/20 0.48
▸ KDM1B Q8NB78 1/20 0.48
▸ RCOR1 Q9UKL0 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25242994 1.00 CTSK (0.61) CTSKCTSBCTSSCTSLCASP1
SCHEMBL25247153 0.99 CTSK (0.63) CTSKCTSBCTSSCTSLCASP1
SCHEMBL25286871 0.99 CTSK (0.63) CTSKCTSBCTSSCTSLCASP1
Hydrochloric Acid SCHEMBL25288896 0.94 CTSK (0.54) CTSKCTSBCTSSCTSLTACR1
Hydrochloric Acid SCHEMBL25288895 0.94 CTSK (0.54) CTSKCTSBCTSSCTSLTACR1
SCHEMBL25282430 0.89 CTSK (0.65) CTSKCTSBCTSSCTSLCASP1
SCHEMBL25282429 0.89 CTSK (0.65) CTSKCTSBCTSSCTSLCASP1
SCHEMBL25290639 0.88 CTSK (0.61) CTSKCTSBCTSSCTSLCASP1
SCHEMBL25290638 0.88 CTSK (0.61) CTSKCTSBCTSSCTSLCASP1
SCHEMBL4622697 0.88 CTSK (0.67) CTSKCTSBCTSSCTSLCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116438160-A Carbamoyl compounds for the treatment of viral infections 豪夫迈·罗氏有限公司 2023-07-14 — — CN disclosed
EP-4204393-A1 AMINOCARBAMOYL COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS F. Hoffmann-La Roche AG (CH) 2023-07-05 — — EP disclosed
WO-2022043374-A1 AMINOCARBAMOYL COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS F. HOFFMANN-LA ROCHE AG (CH) 2022-03-03 — — WO disclosed
Send feedback